A novel sulindac derivative lacking COX-inhibitory activities suppresses carcinogenesis in the transgenic adenocarcinoma of mouse prostate model

Nonsteroidal anti-inflammatory drugs (NSAIDs) including sulindac are well-documented to be highly effective for cancer chemoprevention. However, their cyclooxygenase (COX) inhibitory activities cause severe gastrointestinal and cardiovascular toxicities, limiting their chronic use. Recent studies su...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Prev Res (Phila)
Autors principals: Zhang, Yong, Zhang, Jinhui, Wang, Lei, Quealy, Emily, Gary, Bernard D., Reynolds, Robert C., Piazza, Gary A., Lü, Junxuan
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4990820/
https://ncbi.nlm.nih.gov/pubmed/20587701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-09-0273
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars